Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Part D Rebates Can Pay For Filling In Donut Hole, CBO Says

This article was originally published in The Pink Sheet Daily

Executive Summary

Rebates for Medicare/Medicaid dual eligible enrollees would generate $63 billion over 10 years, Congressional Budget Office estimates; phase-out of donut hole would cost only $47 billion, but most expensive years come after 10 year budget window.

You may also be interested in...



House Health Reform Bill Nets $48 Bil. From Pharma - CBO

The Congressional Budget Office has put a value on the net savings that would accrue to the federal government through drug rebate and discount provisions in the pending House health care reform bill: $48 billion over 10 years

House Health Reform Bill Nets $48 Bil. From Pharma - CBO

The Congressional Budget Office has put a value on the net savings that would accrue to the federal government through drug rebate and discount provisions in the pending House health care reform bill: $48 billion over 10 years

PhRMA Health Reform Deal Is Not Binding On House, Rep. Waxman Declares

Waxman will keep pushing for Part D rebates to help fund closing the coverage gap, regardless of PhRMA's proposal for a different discount model. The good news for industry is that "dollars for donuts" remains the formula--and that even Waxman thinks industry will end up getting more than it gives.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS069809

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel